In recent trading session, Scilex Holding Company (NASDAQ:SCLX) saw 0.52 million shares changing hands at last check today with its beta currently measuring 1.08. Company’s recent per share price level of $0.40 trading at -$0.04 or -8.48% at last check today assigns it a market valuation of $97.98M. That most recent trading price of SCLX’s stock is at a discount of -557.5% from its 52-week high price of $2.63 and is indicating a premium of 5.0% from its 52-week low price of $0.38. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.52 million shares which gives us an average trading volume of 1.91 million if we extend that period to 3-months.
For Scilex Holding Company (SCLX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.09 in the current quarter.
Scilex Holding Company (NASDAQ:SCLX) trade information
Upright in the red during last session for losing -8.48%, in the last five days SCLX remained trading in the red while hitting it’s week-highest on Monday, 01/27/25 when the stock touched $0.40 price level, adding 16.65% to its value on the day. Scilex Holding Company’s shares saw a change of -5.56% in year-to-date performance and have moved -8.56% in past 5-day. Scilex Holding Company (NASDAQ:SCLX) showed a performance of -4.37% in past 30-days. Number of shares sold short was 4.91 million shares which calculate 3.25 days to cover the short interests.
Scilex Holding Company (SCLX) estimates and forecasts
Statistics highlight that Scilex Holding Company is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -74.67% of value to its shares in past 6 months, showing an annual growth rate of 48.39% while that of industry is 16.00. Apart from that, the company came raising its revenue forecast for fiscal year 2025. This year revenue growth is estimated to rise 21.99% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 15.31M for the same. And 3 analysts are in estimates of company making revenue of 17.13M in the next quarter. Company posted 13.46M and 10.88M of sales in current and next quarters respectively a year earlier.
In 2025, company’s earnings growth rate is likely to be around 53.91% while estimates for its earnings growth in next 5 years are of 27.89%.
Scilex Holding Company (NASDAQ:SCLX)’s Major holders
Insiders are in possession of 24.22% of company’s total shares while institution are holding 14.47 percent of that, with stock having share float percentage of 19.09%. Investors also watch the number of corporate investors in a company very closely, which is 14.47% institutions for Scilex Holding Company that are currently holding shares of the company.
On the other hand, SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024, the former fund manager was holding 5.94 shares of worth $2.23 million or 2.44% of the total outstanding shares. The later fund manager was in possession of 3.71 shares on Sep 30, 2024, making its stake of worth around $1.39 million in the company or a holder of 1.53% of company’s stock.
